Fight Over 'Little Pink Pill' Raises Sexism Questions
The drug Flibanserin is locked in a heated battle for approval from the U.S. Food and Drug Administration, raising controversial questions about why there are so many drugs available to help men with sexual dysfunction and zero for women.
